This inventor holds 1 USPTO granted patent. Top assignee: J2h Biotech Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hyung-Jun Kim: Innovator in Pharmaceutical Composition for NASH Treatment
Introduction: Hyung-Jun Kim is a notable inventor based in Asan-Si, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of non-alcoholic steatohepatitis (NASH). His innovative work has led to the development of a pharmaceutical composition that addresses this serious health condition.
Latest Patents: Hyung-Jun Kim holds a patent for a pharmaceutical composition aimed at preventing or treating non-alcoholic steatohepatitis. The invention relates to the medical use of a compound, identified by Chemical Formula 1, which is designed to treat, alleviate, or prevent NASH and hepatic fibrosis. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights: Kim is currently associated with J2H Biotech Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication have positioned him as a valuable asset in the field of biotechnology.
Collaborations: Throughout his career, Hyung-Jun Kim has collaborated with talented individuals such as Jae-Sun Kim and Hyung-Chul Ryu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion: Hyung-Jun Kim's contributions to the treatment of non-alcoholic steatohepatitis through his patented pharmaceutical composition demonstrate his significant impact on medical research and innovation. His work continues to inspire advancements in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile